Skip to search boxSkip to navigationSkip to main content

NOX4-dependent regulation of ENaC in hypertension and diabetic kidney disease

  • Tengis S. Pavlov
    ,
  • Oleg Palygin
    ,
  • Elena Isaeva
    ,
  • Vladislav Levchenko
    ,
  • Sherif Khedr
    ,
  • Gregory Blass
*Corresponding author for this work
  • Medical College of Wisconsin
    ,
  • Henry Ford Health System
    ,
  • Ain Shams University
    ,
  • Western Kentucky University
    ,
  • ,
  • Medical University of South Carolina
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

NADPH oxidase 4 (NOX4) is the most abundant NOX isoform in the kidney; however, its importance for renal function has only recently emerged. The NOX4-dependent pathway regulates many factors essential for proper sodium handling in the distal nephron. However, the functional significance of this pathway in the control of sodium reabsorption during the initiation of chronic kidney disease is not established. The goal of this study was to test Nox4-dependent ENaC regulation in two models: SS hypertension and STZ-induced type 1 diabetes. First, we showed that genetic ablation of Nox4 in Dahl salt-sensitive (SS) rat attenuated a high-salt (HS)-induced increase in epithelial Na+ channel (ENaC) activity in the cortical collecting duct. We also found that H2O2 upregulated ENaC activity, and H2O2 production was reduced in both the renal cortex and medulla in SSNox4−/− rats fed an HS diet. Second, in the streptozotocin model of hyperglycemia-induced renal injury ENaC activity in hyperglycemic animals was elevated in SS but not SSNox4−/− rats. NaCl cotransporter (NCC) expression was increased compared to healthy controls, while expression values between SS and SSNox4−/− groups were similar. These data emphasize a critical contribution of the NOX4-mediated pathway in maladaptive upregulation of ENaC-mediated sodium reabsorption in the distal nephron in the conditions of HS- and hyperglycemia-induced kidney injury.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 13396-13408 (13 pages)

Journal (Volume, Issue Number)

FASEB Journal (Volume 34, Issue 10)

Publication milestones

  • Published - 10/01/2020

Publication status

Published - 10/01/2020

ISSN

0892-6638

Publication IDs

  • Scopus: 85089380202
  • PubMed: 32799394

Publication metrics

Metrics

Fractional count
1
Fractional count
0.11
Fractional count
8
Fractional count
0.89
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
37
Captures
26

Funding Details

This research was supported by the National Heart, Lung, and Blood Institute grants: R35 HL135749, P01 HL116264 (AWC and AS), R01 HL122662 (AWC and AS), R00 HL116603 (TSP), R00 DK105160 (DVI), American Heart Association grants: 16EIA26720006 (AS), and 17SDG33660149 (O. P.), American Society of Nephrology Carl W. Gottschalk Grant (TSP), Dialysis Clinic Inc Reserve Fund C‐4153 (DVI), and Department of Veteran Affairs grant I01 BX004024 (to AS). This research was supported by the National Heart, Lung, and Blood Institute grants: R35 HL135749, P01 HL116264 (AWC and AS), R01 HL122662 (AWC and AS), R00 HL116603 (TSP), R00 DK105160 (DVI), American Heart Association grants: 16EIA26720006 (AS), and 17SDG33660149 (O. P.), American Society of Nephrology Carl W. Gottschalk Grant (TSP), Dialysis Clinic Inc Reserve Fund C-4153 (DVI), and Department of Veteran Affairs grant I01 BX004024 (to AS).
FundersFunding numbers
Dialysis Clinic Inc Reserve Fund C-4153
-
NHLBI
P01 HL116264, R35 HL135749, R00 HL116603, R01 HL122662
NIDDK
R00DK105160
VA
I01 BX004024
AHA
16EIA26720006, 17SDG33660149
DCI
-